scispace - formally typeset
Journal ArticleDOI

Oxidative stress and antioxidants in hypertension-a current review.

Nakshi Sinha, +1 more
- 31 Jul 2015 - 
- Vol. 11, Iss: 2, pp 132-142
TLDR
The aim of this review is to present a novel focus on the role of oxidative stress in the pathophysiology of hypertension and recent biomarkers which are found to be associated with reactive oxygen species and therole of antioxidants as therapy of hypertension.
Abstract
Free radicals or reactive oxygen species (ROS) are generated by oxygen metabolism which is balanced by the rate of oxidant formation and the rate of oxidant elimination. Oxidative stress is a result of imbalance between the generation of reactive oxygen species (ROS) and the antioxidant defence systems. Hypertension is one of the major risk factors for cardiovascular diseases and is considered as a leading cause of mortality and morbidity. These diseases affect more than 600 million people and it has been estimated that 29% of the world population will be suffering from hypertension by 2025. It has been indicated by experimental evidence that reactive oxygen species (ROS) play an important role in the pathophysiology of hypertension. The vasculature is a rich source of NADPH oxidase which produces most of the reactive oxygen species and plays an important role in renal dysfunction and vascular damage. Recent studies indicate that increased oxidative stress is the important mediator of endothelial injury in the pathology of hypertension associated to increased production of pro oxidants such as superoxideanion hydrogen peroxide, reduced nitric oxide synthesis and decreased bioavailability of antioxidants. Oxidative stress is found to be associated with endothelial dysfunction, inflammation, hypertrophy, apoptosis, cell migration, fibrosis, and angiogenesis in relation to vascular remodelling of hypertension. Results in humans are still less conclusive inspite of data available that involve oxidative stress as a causative factor of essential hypertension. The aim of this review is to present a novel focus on the role of oxidative stress in the pathophysiology of hypertension and recent biomarkers which are found to be associated with reactive oxygen species and the role of antioxidants as therapy of hypertension.

read more

Citations
More filters
Journal ArticleDOI

The neuroprotective effect and possible therapeutic application of xenon in neurological diseases.

TL;DR: Xenon is an inert gas with stable chemical properties which is used as an anesthetic and has been shown to have an excellent neuroprotective effect in subanesthetic concentrations as mentioned in this paper.
Journal ArticleDOI

Clinical Impact of Hemorheology on Subclinical Myocardial Injury in Patients with Hypertension.

TL;DR: It is suggested that progression of myocardial injury can be prevented by maintaining WBPT at approximately ≤ 55 s, and the results indicate that WBPT is independently associated with hs-cTnT in hypertensive patients with no history of cardiovascular events.
Journal ArticleDOI

OXY-SCORE: a new perspective for left ventricular hypertrophy diagnosis.

TL;DR: A recently developed global indicator of oxidative stress (OXY-SCORE), by combining individual plasma biomarkers of oxidative damage and antioxidant capacity, has been validated in several pathologies, but not in left ventricular hypertrophy (LVH).
Journal ArticleDOI

Association of OSR‐1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease

TL;DR: Serum OSR‐1 gene expression was significantly increased in hypertensive ADPKD patients in comparison with both normotensive AD PKD counterparts and non‐ADPKD hypertensive subjects and low estimated glomerular filtration rate (eGFR), OSR-1 geneexpression, total kidney volume (TKV), and high‐density lipoprotein (HDL) were also independently associated with hypertension in ADPKd patients.
Journal ArticleDOI

Silencing TRPV4 partially reverses the neurotoxic effects caused by excess Ketamine.

TL;DR: In this article, the effect of Transient Receptor Potential Vanilloid 4 (TRPV4) on KET-induced neurotoxicity in the hippocampus was explored by extracting and identifying rat hippocampal neuronal cells The hippocampal neurons were treated with different concentrations (0, 01, 1, 10, 100, 300 and 1000 μmol/L) of KET (6, 12, 24, and 24 hours).
Related Papers (5)